![Ken Thompson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ken Thompson
Corporate Officer/Principal bij ALS Therapy Development Foundation, Inc.
Profiel
Ken Thompson is currently the Director-Lab Operations at ALS Therapy Development Foundation, Inc. since 2000.
Prior to this, he worked as a Principal at the University of Alaska.
Actieve functies van Ken Thompson
Bedrijven | Functie | Begin |
---|---|---|
ALS Therapy Development Foundation, Inc.
![]() ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-01-2000 |
Eerdere bekende functies van Ken Thompson
Bedrijven | Functie | Einde |
---|---|---|
University of Alaska | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
ALS Therapy Development Foundation, Inc.
![]() ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | Health Technology |